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In 2017, the United States Department of Health and Human Services declared 
that the country was experiencing an opioid crisis (U.S. Department of Health and 
Human Services, 2018).  As a result of this phenomenon, healthcare providers are 
examining how they are managing pain and researching new avenues for the treatment of 
pain.  Anesthesia providers are in a unique position to help reduce postoperative pain and 
ultimately the development of chronic pain.  This doctoral project was conducted in order 
to write an evidence-based policy that directs and educates anesthesia providers in the 
administration of intraoperative ketamine to reduce postoperative pain in patients 
undergoing spinal surgery.  A review of the evidence and collaboration with a physician 
anesthesiologist contributed to the creation of the policy.  A presentation of the evidence 
and policy was given to a panel of experts.  The policy was evaluated using a survey 
provided to the experts.  The feedback provided by the panel of experts revealed that the 
policy provided the information needed to inform the anesthesia providers about the 
current best practice regarding intraoperative ketamine administration for reducing 
postoperative pain.  The panel also agreed that the information provided changed their 
practice in regard to adding ketamine as an adjunct therapy.  An executive summary was 
completed after reviewing the feedback provided by the panel of experts and presented to 
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CHAPTER I - INTRODUCTION 
According to the Centers for Disease Control and Prevention (CDC), the State of 
Mississippi is among the top 10 in the United States in the number of opioid prescriptions 
written each year.  In 2014, 120 opioid prescriptions were written per 100 Mississippi 
residents (CDC, 2017).  Acute postoperative pain that is poorly controlled within the first 
three postoperative days is considered to be a trigger for chronic pain, so it is important 
for anesthesia providers to utilize multimodal pain management strategies in an effort to 
prevent chronic pain.  Spinal surgery patients are at a greater risk for having suboptimal 
pain control after surgery for two reasons.  First, spinal surgery patients are more likely 
taking opioids for pain management at home due to preexisting chronic back pain (Bajwa 
& Haldar, 2015).  Second, the surgery itself is also known to be very painful due to the 
extensive incision and tissue retraction (Bajwa & Haldar, 2015).  The addition of 
ketamine into a multimodal pain management plan reduces centralized excitability and 
decreases opioid tolerance, which effectively decreases postoperative pain.  The purpose 
of this Doctor of Nursing Practice (DNP) project was to create a policy that guides 
anesthesia providers in the timing, dosage, and exclusion criteria for administration of 
intraoperative ketamine. 
Background and Significance 
Ketamine is an N-Methyl-D-aspartate (NMDA) noncompetitive antagonist that 
directly affects the central nervous system by preventing sensitization of the nociceptive 
pathway (Bajwa & Haldar, 2015).  In essence, ketamine’s mechanism of action can 
prevent the severe pain expected from surgery as well as the development of chronic pain 
that arises from central sensitization and hyperalgesia (Gao, Rejaei, & Liu, 2016).  As an 
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NMDA receptor antagonist, ketamine also reduces previous opioid tolerance, which 
decreases the amount of narcotics the patient requires to achieve the same level of pain 
control (Bajwa & Haldar, 2015).  The American Pain Society Practice Guideline for the 
Management of Acute Postoperative Pain (Chou et al., 2016) suggested the use of 
intraoperative ketamine as part of a multimodal pain management plan which is 
specifically useful in painful surgical procedures as well as for those patients who have 
opioid tolerance.  In order to achieve the best results, timing and dosage of intraoperative 
ketamine are essential.  A bolus dose of ketamine between induction and skin incision 
followed by a low dose maintenance infusion to be stopped upon wound closure provide 
the most optimal effect (Chou et al., 2016).   
Spinal surgeries were recently named in the top six most painful surgical 
procedures; therefore, creating a high quality, multimodal pain management plan is 
essential for improving patient care (Bajwa & Haldar, 2015).  Unlike other orthopedic 
procedures, spinal surgery patients cannot benefit from the use of neuraxial or regional 
anesthesia to reduce postoperative pain.  Patients who undergo spinal surgery are already 
more likely to be experiencing chronic pain and have an increased tolerance to narcotics. 
Patients with poorly managed postoperative pain have a delay in surgical recovery, 
hospital readmissions for pain management, and decreased patient satisfaction.   
In order to best address the methods by which providers are treating postoperative 
pain, the American Pain Society (APS) suggested that specific policies, which are 
focused on safe and evidence-based treatments, should be created (Chou et al., 2016).  
Clinical policies standardize care amongst patients as well as provide a reliable reference 
for providers to use within their practice.  Pain management strategies should be 
 3 
procedure-specific because each surgical procedure affects the body in different ways, 
and procedure-specific pain management would take into account the expectations for 
recovery after the surgery (Kehlet, Wilkinson, Fischer, & Camu, 2007).  The American 
Society for Anesthesiologists (ASA) recommends anesthesia providers develop 
institutional policies and protocols to standardize care, improve patient outcomes, and 
reduce anesthesia care gaps (ASA Task Force on Acute Pain Management, 2012).  
Currently, the use of intraoperative ketamine varies from provider to provider.  A policy 
will establish an institutionally preferred dose range, administration time, and exclusion 
criteria. 
Problem Statement 
According to the CDC (2017), the number of opioid prescriptions written in 2013 
was equal to the number of American adults.  The opioid problem is not just invading 
metropolitan areas of the country, but some of the most rural states (e.g., Mississippi) are 
the most affected.  Prescription opioid abuse is tied to badly managed postoperative pain 
and the development of chronic pain.  Anesthesia providers are in a unique position to 
help decrease the intensity of postoperative pain, adequately manage acute pain, and 
possibly prevent the development of chronic pain all by using a multimodal pain 
management strategy.  Intraoperative ketamine has been shown to be an effective puzzle 
piece within multimodal pain management.  As it currently stands, ketamine 
administration varies from provider to provider.  The development of an intraoperative 
ketamine policy will standardize ketamine administration among providers and supply a 
useful resource for providers to use in the development of their anesthesia plan. 
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Purpose of the Project 
The purpose of this project was to create an intraoperative ketamine infusion 
policy using evidence-based practice and best practice recommendations to reduce 
postoperative pain in spinal surgery patients at an orthopedic specialty hospital in 
southeast Mississippi.  Ketamine was first introduced to the market in the 1970s, but 
using low dose intraoperative ketamine as an adjunctive therapy for pain management is 
still a relatively new concept that is gaining favor among anesthesia providers nationwide 
(Bell, Dahl, Moore, & Kalso, 2015).  A policy provided a straightforward reference for 
dosage and timing of administration as well as patient exclusion criteria.  A policy, along 
with anesthesia provider education, should increase the provider receptiveness to adding 
intraoperative ketamine for spinal surgery patients to their pain management plan.   
Needs Assessment 
A needs assessment was performed at a south Mississippi orthopedic surgery 
center in the fall of 2017.  A gap in knowledge among providers was found about dosing 
and timing recommendations for intraoperative ketamine during spinal surgery.  After 
surveying, it was evident that anesthesia providers were also unaware of the benefits that 
low-dose ketamine provides to spinal surgery patients and felt that it was a hassle to 
prepare.  A clear and concise policy that details the timing, dosage, and type of 
administration may well increase the consistency with which intraoperative ketamine is 
administered as well as increase the likelihood of administration. 
Conceptual Framework 
The conceptual framework of this study was Bardach’s eightfold model for policy 
analysis.  Bardach (2012) stated that policy analysis requires as much intuition as science 
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and, therefore, is an art which merely requires straightforward steps as a guide, which is 
how he developed his eight-step model.  The eight steps are as follows: define the 
problem, assemble evidence, construct alternatives, select criteria, project outcomes, 
confront the trade-offs, evaluate, and present the findings.  According to Bardach (2012), 
the process starts by defining your problem and inevitably ends by presenting the results.  
The other steps do not necessarily need to happen in the exact order he presented them.  
The benefit to Bardach’s model is flexibility.  The user can apply Bardach’s model to his 
or her own plan and easily make changes to better fit the problem.   
Steps 1 through 4 were the foundation for the current proposed policy.  First, the 
problem must be defined.  The problem is the lack of knowledge, understanding, and 
consistency behind the administration of ketamine intraoperatively to reduce pain for 
spinal surgery patients in the postoperative period.  The next step is to gather and 
assemble evidence to educate and construct a policy that will guide anesthesia providers 
in the administration of ketamine for spinal surgery patients.  The policy will detail 
patient selection and exclusion criteria.  Steps 5 through 8 will define the outcomes, 
assess for barriers, and evaluate the policy.  The ultimate outcome for this project was to 
create a policy for the administration of intraoperative ketamine for spinal surgery 
patients.  Before the policy can be evaluated, barriers must be addressed that will define 
the practice of the anesthesia providers.  Barriers may include the perception of intrusion 
in the anesthesia provider’s personal practice, a provider’s disbelief in the effectiveness 
of ketamine for postoperative pain relief, and the current national shortage of the 
ketamine supply.  The initial policy was presented to the anesthesia providers who were 
the most affected by the policy for their evaluation and input.  A survey was provided for 
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feedback on the policy.  After reviewing the feedback within the surveys that were 
submitted, a finalized policy was created.  Finally, the policy was presented to the 
stakeholders at the orthopedic specialty hospital for consideration as best practice for 
intraoperative ketamine. 
DNP Essentials 
The American Association of the Colleges of Nursing outlined eight essential 
elements for completion of a DNP (DNP Essentials Task Force, 2006).  This project will 
meet each essential; each essential is listed as follows:  
• Essential I, Scientific Underpinnings for Practice (Chism, 2015).  
A review of current literature for practice recommendations associated with 
intraoperative ketamine dosage and timing satisfied Essential I.  The informational 
data gathered included practice recommendations and best practice guidelines that 
provide recommendations for intraoperative ketamine administration. 
• Essential II, Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking (Chism, 2015).  Essential II was met by creating a policy to 
anesthesia providers who will standardize intraoperative ketamine administration for 
spinal surgery, which will ultimately improve the quality of anesthetic provided by 
the anesthesia staff.  Before implementing the policy, anesthesia provider education 
shed light on the need and importance of the policy.   
• Essential III. Clinical Scholarship and Analytical Methods for Evidence-Based 
Practice (Chism, 2015)  A literature review included gathering practice guidelines 
supported by evidence which included recommendations for intraoperative ketamine 
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infusions.  Analyzing the best practice guidelines and comparing their evidence to the 
evidence that the current literature review revealed met Essential III. 
• Essential IV. Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care (Chism, 2015)  The project 
intervention was created with information technology, and the project intervention 
was created with information technology.  Patient care technology was utilized as part 
of the policy.  An intraoperative ketamine infusion requires an intravenous (IV) 
infusion pump for accurate administration. 
• Essential V. Health Care Policy for Advocacy in Health Care (Chism, 2015). 
Multimodal pain management was created to address the healthcare problem that was 
created by using just one method for pain management.  The ultimate inspiration for 
this project was to provide an effective alternative to manage pain specifically to a 
population that usually has difficulty achieving adequate pain relief.  Essential V was 
met with the creation of a policy with the intention of improving health care. 
• Essential VI. Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes (Chism, 2015).  Collaboration with the anesthesia providers, 
stakeholders, and nurse anesthesia program faculty met Essential VI. 
• Essential VII. Clinical Prevention and Population Health for Improving the Nation’s 
Health (Chism, 2015).  A secondary goal of the policy created was to reduce 
postoperative pain and the amount of narcotics required to treat pain during a 
patient’s recovery from spinal surgery.  By educating providers about the benefits of 
intraoperative ketamine, this DNP project may foster the understanding that 
anesthesia can benefit a patient far outside of the operating room and past the end of 
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anesthesia time.  Essential VII was met by educating providers about the potential 
long-term benefits a patient can receive by using intraoperative ketamine. 
• Essential VIII. Advanced Nursing Practice (Chism, 2015).  Advanced practice nurses 
were expected to analyze current best practice and implement those guidelines in their 
practice.  Analyzing best practice guidelines and educating current providers about 
the recommendations specific to their practice met Essential VIII. 
Review of Evidence 
An evidence search was performed to explore the available evidence 
demonstrating that a perioperative dose of ketamine decreases pain in the postoperative 
period and how the researchers were able to prove ketamine’s effectiveness.  Several 
databases, including CINAHL with Full Text, Medline, PubMed, Cochrane, and Google 
Scholar, were searched for relevant articles.  The following key search terms were 
utilized: ketamine, perioperative, spine surgery, acute pain, and opioid sparing.  An initial 
search with limitations to full text only and publication dates between 2001 and 2018 
returned 98 articles after duplications were removed.  Upon further review of all 
databases accessed, a total of eight articles were selected because they were strongly 
applicable to this project.  An evidence matrix is included with information from each of 
the included articles (see Appendix A).     
Pain Management and Spinal Surgery 
“Due to the extensive damage of soft tissues and muscles surrounding the 
vertebral column” (Garg et al., 2016, p. 1), patients who undergo spinal surgery can 
experience intense pain postoperatively.  The mismanagement of acute postoperative pain 
in spinal surgery patients leads to poor outcomes, such as a “delayed recovery, poor 
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rehabilitation, and progression to chronic pain” (Garg et al., 2016, p. 1).  Therefore, it is 
imperative for anesthesia providers to be mindful of the increased risk for spinal surgery 
patients to experience inadequate pain management and to be aggressive in treating the 
known causes of pain to prevent poor surgical outcomes.  According to Garg et al. 
(2016), low-dose ketamine provides analgesia with limited side effects due to the 
inhibition of the NMDA receptor and also is shown to occupy opiate receptors in the 
brain and spinal cord.  The centrally acting analgesia ketamine provided lends itself to be 
especially effective in spinal surgery cases.   
A study comparing the effects of ketamine and dexmedetomidine on 
postoperative pain in spinal surgery found that the patients who received a bolus dose of 
ketamine at induction (0.25 mg/kg) followed by an infusion (0.25 mg/kg/hr) reported the 
lowest pain scores postoperatively (Garg et al., 2016).  Garg et al. (2016) also reported 
that the patients who received ketamine intraoperatively had a 74% reduction in opioid 
requirements after surgery.  Loftus et al. (2010) studied the effect of using low-dose 
ketamine intraoperatively to reduce opioid requirements after spinal surgery in patients 
with chronic back pain.  The patients received a bolus dose of ketamine at induction (0.5 
mg/kg) followed by an infusion (10 mcg/kg/min) initiated before skin incision and 
maintained until wound closure (Loftus et al., 2010).  The study’s results showed a 
decrease in intraoperative opioid requirements by 24%, a 37% decrease in opioid 
consumption up to 48 hours postoperatively, and a 26% decrease in pain intensity 
postoperatively that lasted up to a 6-week follow-up visit (Loftus et al., 2010).  In July 
2018, a joint effort by the American Society of Regional Anesthesia, American Academy 
of Pain Medicine, and the American Society of Anesthesiologists released the consensus 
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guidelines for using ketamine as an adjunctive therapy to treat pain (Schwenk et al., 
2018).  According to Schwenk et al. (2018), ketamine is most useful in reducing acute 
postoperative pain in patients who are undergoing painful surgery, such as spinal 
surgeries, as well as for patients who are opioid-tolerant.  
Low Dose Ketamine and Pain 
When ketamine was released into the market in 1970, it was believed to quickly 
replace other induction agents because it provided amnesia, analgesia, and anesthesia 
while maintaining a patient’s hemodynamic stability (Gao et al., 2016).  After a few years 
on the market, patients experienced the severe neurological symptoms, such as 
hallucinations, more frequently than initially expected when given the full anesthetic dose 
of ketamine (Gao et al., 2016).  The anesthetic dose or induction dose of ketamine is 1-2 
mg/kg (Gao et al., 2016).  The increase in the incidence of hallucinations and other 
neurological symptoms make providers wary of using full-dose ketamine unless the 
patient’s hemodynamically stability is in question.  Within the last decade, alternative 
uses for ketamine have surfaced.  Sub-anesthetic doses of ketamine are being used to 
treat chronic pain, acute pain, mood disorders, and post-traumatic stress disorder without 
the side effects seen in a full-anesthetic dose (Gao et al., 2016).   
 Ketamine attenuates pain by “decreasing central excitability, decreasing acute 
postoperative opiate tolerance, and modulation of opiate receptors” (Loftus et al., 2010., 
p. 639).  A low-dose ketamine infusion, when administered at 10 mcg/kg/min 
intraoperatively, has been shown to reduce the amount of opioids required after surgery 
to manage pain (Loftus et al., 2010.).  The opioid-sparing effect of ketamine is beneficial 
because by reducing the need for opioids there is also a reduction in the opioid-related 
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side effects, such as respiratory depression, nausea and vomiting, and hyperalgesia (Garg 
et al., 2016).  Adjunctive doses of ketamine intraoperative are helpful to patients who are 
most at risk for developing opioid-related respiratory depression, such as patients with 
obstructive sleep apnea (Schwenk et al., 2018). 
Recommendations for Multimodal Pain Management 
According to a United States (U.S.) survey to discover the incidence in 
postoperative pain in 2014, nearly half of postoperative surgical patients reported 
undermanaged pain during their recovery, and 75% of postoperative surgical patients 
rated their pain as high or severe (Gan et al., 2014).  Unmanaged acute, postoperative 
pain can lead to the development of chronic pain.  The APS released an updated guideline 
for the management of postoperative pain.  APS “strongly recommends the use the 
multimodal analgesia, using a variety of medication and technique to have a more 
synergistic, effective approach to pain relief than single-modality intervention” (Chou et 
al., 2016, p. 254).”  Despite evidence that a multimodal pain management reduces acute 
postoperative pain, opioids are still the main method of pain management in the operating 
room (White & Kehlet, 2010).  Anesthesia providers need to be more mindful of how 
they are treating postoperative pain now more than ever because they can either be the 
cause of a problem or the solution to it.  White and Kehlet (2010) suggested the best way 
to reduce postoperative pain is to implement best practice recommendations for 
multimodal pain management techniques supplemented with opioids if needed.  




Chapter 1 included the background, significance, project purpose, problem 
statement, needs assessment, and DNP Essentials.  This chapter also included a review of 
current evidence that supported the development of this project.  Chapter II discusses the 
methods utilized in the completion of this DNP project.  
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CHAPTER II - METHODOLOGY 
Target Outcome 
The objective of this doctoral project was to create a policy on intraoperative 
ketamine administration for spinal surgery for a healthcare facility in southeastern 
Mississippi that specializes in orthopedic surgery.  The policy was created in 
collaboration with a physician anesthesiologist, who chiefly oversees anesthesia care at 
the facility, followed by a thorough review of the evidence and current practice 
guidelines.  A copy of the policy is provided in Appendix B.  The policy included 
specific dosing and timing of administration guidelines to facilitate the use of 
intraoperative ketamine among anesthesia providers within the facility.  An executive 
summary of the doctoral project, as well as the initial draft of the policy, were presented 
to a panel of experts (e.g., the physician anesthesiologist, CRNAs, hospital 
administrators, and pharmacists).  The panel of experts was chosen to provide feedback 
on each aspect of the policy from the structure to the content.  The anesthesia providers 
and pharmacists selected were able to comment on the content of the policy, and the 
hospital administrators were able to give feedback on the structure of the policy itself.  
Once the panel of experts had reviewed the executive summary as well as the policy, they 
were provided feedback via a survey.  A copy of the survey is provided in Appendix C.  
The survey was used to gather evidence on how to improve the policy for future 
implementation at the facility.  The short-term goal of this doctoral project was to 
establish a policy based on evidence-based practice for the administration of 
intraoperative ketamine.  The long-term goal of this doctoral project was to provide a 
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reference for anesthesia providers to elevate their care to standardized evidence-based 
practice. 
Population 
For this doctoral project, the main focused population included patients who were 
undergoing spinal surgery at the specialty orthopedic facility in southeastern Mississippi 
unless they met exclusion criteria.  The exclusion criteria for this project included 
patients with a known intolerance or allergy to ketamine, over 70 years old, an increased 
intraocular pressure (IOP), uncontrolled hypertension (HTN), increased intracranial 
pressure (ICP), pregnancy, and history for seizure disorder.  Prior to implementation of 
this study, approval was obtained from The University of Southern Mississippi’s 
Institutional Review Board (Protocol # 18070602) (see Appendix D). 
Design 
A policy was created after a thorough review of the evidence and best practice 
guidelines.  The DNP student collaborated with a physician anesthesiologist who wished 
to develop a policy for his facility.  The policy delineated the correct dosage as well as 
the timing of administration of intraoperative ketamine supported by the evidence.  The 
policy provided administration guidelines, such as patient exclusion criteria to promote 
safe administration.  In order to promote the use of the policy, a short explanation of the 
evidence that supported the policy’s guidelines was included in the form of an executive 
summary.  The executive summary is included in Appendix E.  A panel of experts, 
including pharmacists, CRNAs, and the physician anesthesiologist was presented with the 
initial policy.  A survey was provided to give feedback to the DNP student.  The survey 
essentially asked the following questions:  
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1. Did this project presentation provide you with information regarding intraoperative 
ketamine administration that reduces postoperative pain for patients undergoing 
spinal surgery?  
2. Did the information provided in this presentation encourage you to reconsider your 
current anesthesia practice?  
3. Would you consider changing your practice based on the information presented if 
given the option of utilizing ketamine as an adjunctive therapy?  
The last question asked for comments and suggestions regarding the policy.  The 
DNP student collected data via surveys.  After analyzing data provided by the surveys, 
the DNP student evaluated the changes against current best practice and information 
gathered during the literature review.  The findings were included in the executive 
summary.  Once data were evaluated, the DNP student altered the policy per the 
recommendations provided through the surveys and evidence.  Once the final policy was 
approved by the collaborating physician anesthesiologist, the DNP student presented the 
finalized policy to the panel of experts and DNP committee members to evaluate the 
project by the DNP essentials and validate the project as doctorate level work.  During 
the final presentation, the DNP student provided recommendations and an executive 
summary to the orthopedic specialty facility based on data, evidence review, the facility’s 
anesthesia providers, and a panel of experts’ opinions. 
Limitations 
In order to effect positive change, it was important to understand the challenges 
that surfaced during the process.  The first barrier realized was institutional culture.  If the 
institution was unwilling to allow a change, it would immediately halt progress.  By 
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collaborating with a physician anesthesiologist who is willing to support this doctoral 
project, the institution was more willing to allow this change.  A future barrier was the 
implementation of the policy due to provider culture.  The providers needed to accept 
change and be willing to change their practice in order for this project’s long-term goals 
to be fulfilled.  This barrier was addressed during the creation of the policy.  The 
feedback provided by the experts the led to creation of a policy appropriate and user-
friendly. 
Summary 
Chapter II detailed the target outcome of this DNP project.  Also included in 
Chapter II were the population of interest, design, and limitations.  The results of the 
project are outlined in Chapter III.    
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CHAPTER III  - RESULTS 
A combination of a thorough literature review of current best practice 
recommendations and a 5-question survey that provided feedback from a panel of experts 
about the initial policy was employed for this DNP project.  Those individuals on the 
panel of experts included a hospital administrator, pharmacist, chief physician 
anesthesiologist, and 9 CRNAs who routinely provide care for patients undergoing spinal 
surgery at the orthopedic specialty facility.  The panel was constructed of members who 
possess the most knowledge and influence over the care of patients undergoing spinal 
surgery.  The panel members also were most affected by policy implementation.  
Therefore, the experts chosen provided influential feedback on the policy structure and 
included information within the policy.  Members of the panel were presented with the 
best practice information regarding the timing, dosage, and administration of 
intraoperative ketamine and were instructed to review the policy afterward.  Once they 
had reviewed the policy, the panel asked for feedback using the 5-question survey.  Each 
participant agreed that the policy provided them with information on how intraoperative 
ketamine administration reduces postoperative pain for spinal surgery patients.  Only one 
participant answered, “No,” when asked if the information provided encouraged them to 
reconsider changing their current practice.  Within the comments section of the survey, it 
was revealed that this participant already uses ketamine intraoperatively for specific 
spinal surgery cases; therefore, the presentation reaffirmed this participant’s practice. 
Finally, each participant agreed that based on the information provided they would 
change their practice if given the opportunity of utilizing ketamine as an adjunctive 
therapy.   
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The survey results revealed that the information within the policy adequately 
explained the evidence for the use of intraoperative ketamine to reduce postoperative pain 
in spinal surgery patients as well as the evidence-based method for administration.  
Participants also revealed a willingness to change their practice to incorporate 
intraoperative ketamine administration which tackles one of the proposed future barriers 
to the implementation of the policy.  In the comments and suggestions section of the 
survey, one participant recommended a way to combat the ketamine shortage was 
involving the perioperative pharmacists that manage the distribution of medication trays, 
antibiotics, and infusions.  The pharmacist can separate a vial of ketamine into individual 
infusions and bolus doses, which decreases waste and cost of the adjunctive therapy.  
Once the intraoperative ketamine policy was implemented, including the change 
suggested above, the practices in this facility improved. 
Summary 
In Chapter III, the results from the survey of the panel of experts were reviewed 
and analyzed.  The data revealed that the policy created for this DNP project met the 
target outcomes outlined in Chapter II.  Chapter IV will present the findings of this 
project.
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CHAPTER IV – CONCLUSION 
Summary 
Multimodal pain management has been hailed as the gold standard by the ASA 
(2012), yet many providers rely heavily on a single treatment modality to treat pain.  The 
purpose of this DNP project was to create a policy which outlines the best practice for 
intraoperative ketamine administration for spinal surgery patients in order to facilitate the 
use of ketamine as an adjunctive treatment.  By providing all the information required to 
include ketamine into the anesthesia plan, the policy made integrating the adjunctive 
therapy easier for the providers.  The data revealed that the information provided within 
the policy increased the willingness to incorporate ketamine into their anesthesia practice.  
This information may lead the way for future policies that enhance postoperative 
outcomes. 
Interpretation 
The evidence is clear that the anesthetic provided to spinal surgery patients has an 
effect on patients well into the postoperative period.  Policies such as the one created for 
this DNP project give anesthesia providers the tools necessary for developing a 
multimodal anesthetic that ensures the best recovery possible for each patient.  In order to 
successfully implement a policy, the institutional culture must be amenable to change.  
Based on the information gathered by this project, once an institution is ready to 
incorporate changes into their practice, all that is required is a policy which provides 
evidence-based practice for the intervention. 
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Implications for Future Practice 
Once the intraoperative ketamine policy was implemented, a retrospective 
analysis comparing patients’ pain scores as well as the opioid consumption 
postoperatively was performed.  The retrospective analysis was performed after using 
intraoperative ketamine policy for 6 months in order to gather adequate evidence to 
compare the two data sets.  This doctoral student believes that having the patient data that 
proves the effectiveness of intraoperative ketamine for the population of south 
Mississippi will lead to the creation of similar policies in other facilities in the area as 
well as reinforce the evidence that already exists within the literature.  Intraoperative 
ketamine administration as an adjunct was shown to be effective in reducing 
postoperative pain for several types of procedures.  The doctoral student recommends 
that the policy should be extended to include other procedures similar to spinal surgeries 
which limit the use of regional anesthesia for postoperative pain control. 
Conclusions 
Despite the opioid epidemic that is affecting the nation, patients are still 
experiencing inadequate pain control after surgery.  Improperly managed pain 
postoperatively increases the length of hospital stay and can lead to the development of 
chronic pain.  Anesthesia providers are uniquely placed to preemptively treat the 
expected pain from surgery and reduce postoperative pain by using a multimodal pain 
management technique that includes intraoperative ketamine.  The objective of this DNP 
project was to create a policy, in collaboration with a physician anesthesiologist and a 
thorough review of the current evidence, that details the timing, dosage, and 
administration of intraoperative ketamine for the purpose of reducing postoperative pain.  
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The participants agreed once presented with the policy that they would change their 
practice to include intraoperative ketamine, and the policy that was created adequately 
provides them with the information required to use the technique. 
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N/A Spinal surgery is in the 
top six most painful 
procedures for patients.   
Aggressive pain control 
improves the success of 
the surgery and the 
outcomes for the 
patients. 
 
Experts suggest that 
multimodal therapy is 
the best way to manage 
pain in patients 
undergoing spinal 
surgery. 
Effective pain control is 
shown to improve the 
outcomes in spinal 
surgery patients.  Using 
multimodal treatments to 
attack pain in various 
pathways versus just one 
is the best method of 
treatment and provides a 
better outcome for the 
patients. 
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 Facilities in which 
surgery is performed 
should have an 
organizational structure 
to oversee the 
development, 
implementation, and 
evaluation of policies 
and practices to assure 
safe, evidence-based, 
and effective post- 
operative pain and the 
development of chronic 
pain. 
The Panel recommends 
that facilities in which 
surgery is performed have 
an organizational structure 
in place to develop and 
refine policies and 
processes for safe and 
effective delivery of 
postoperative pain control. 
 
The Panel recommends 
that clinicians consider 
ketamine as a component 




































periods in the 
ketamine group 
(860 min) and the 
dexmedetomidine 
group (580 min) 
were longer than 
in the saline 
group (265 min) 
(p < 0.002) during 
the observation 
period of 48 
hours.  There was 
a significant 
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  Findings support the 
use of a bolus dose 
and infusion for 
perioperative pain 
management with the 





demonstrates a clear 
short-term, opioid-
sparing effect when 
ketamine is used in 
subanesthetic doses 
as a perioperative 
adjunct. 
Evidence supports the 
use of Ketamine for 
acute pain in a variety of 
contexts, including as a 
stand-alone treatment, 
as an adjunct to opioids, 
and, to a lesser extent, 
as an intranasal 
formulation.  
Contraindications for 
acute pain are similar to 
those for chronic pain, 
partly based on the 
observation that the 
dosage ranges are 
similar. 
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APPENDIX B – CLINICAL POLICY 
Clinical Policy 
 
PERIOPERATIVE KETAMINE ADMINISTRATION FOR SPINE SURGERY 
1. Policy Statement 
This document details guidelines for the administration of Ketamine in the 
perioperative period for patients undergoing spine surgery.  The addition of 
Ketamine into a multi-modal pain management regimen will provide an effective 
decrease in postoperative pain. 
 
2. Background 
Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has been 
shown to reduce pain by decreasing central excitability and opioid tolerance.  The 
reduction in pain is demonstrated by a reduced amount of opioids consumed by 
the patient during their recovery.  Ketamine is considered a dissociative anesthetic 
and may produce hallucinations.  A pre-operative 1-2 mg dose of a 
benzodiazepine, Midazolam, exponentially decreases the risk of the dissociative 







4. Plan of Care 
Patient Selection 
• Patients undergoing spinal surgery at the Orthopedic Institute of 
Forrest Health, unless they meet any of the criteria for exclusion. 
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Exclusion Criteria 
• Known Intolerance or Allergy to Ketamine 
• Increased Intraocular Pressure (IOP) 
• Uncontrolled Hypertension (HTN) 
• Increased Intracranial Pressure (ICP)  
• Pregnancy 
• History of a Seizure Disorder 
 
Preparation 
• Midazolam 1-2 mg pre-operative dose 
• Ketamine 0.5 mg/kg for a bolus dose at induction 
• Infusion: mix 250 mg Ketamine in a 250 mL bag of 0.9% Normal 
Saline, making the infusion concentration 1 mg/mL.  Set up and 
program the IV pump for 10 mcg/kg/min administration.   
   
Administration 
Before bringing the patient back for their surgery, administer 1-2 mg 
Midazolam.   
In addition to the patient-specific anesthetic plan for induction, add a bolus 
dose of Ketamine 0.5 mg/kg. Maintain the patient on the volatile 
inhalation agent or intravenous agent of choice, in accordance with 
surgical requirements and patient’s needs.  Before the surgical incision is 
made, connect the Ketamine infusion tubing onto a port on the main IV 
fluid line. Start the Ketamine infusion at 10 mcg/kg/min. At the time of 
wound closure, turn off the Ketamine infusion.   
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APPENDIX C – EVALUATION TOOL 
Participation in this anonymous questionnaire is voluntary.  There are no repercussions 
for nonparticipation.  Thank you for your time. 
 
Please answer the following questions with a Yes or No response. 
1. Did this project presentation provide you with information regarding 
intraoperative ketamine administration that reduces postoperative pain for patients 




2. Did the information provided in this presentation encourage you to reconsider 




3. Would you consider changing your practice based on the information presented if 
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APPENDIX E - EXECUTIVE SUMMARY 
Despite a shift in focus within the last 20 years towards providing adequate and 
achievable postoperative pain relief, approximately 70% of patients can still expect to 
wake up in recovery with moderate to severe pain.  The American Pain Society (APS), 
American Society of Anesthesiologists (ASA), and the American Association of Nurse 
Anesthetists (AANA) all agree that the best method for postoperative pain management is 
through a multimodal approach aimed at treating multiple pathways for pain.   
Unfortunately, despite the evidence proving that a multimodal pain management 
approach is most effective, many anesthesia providers are still using strictly opioids as 
their main method for treating postoperative pain.  Postoperative pain carries many risks, 
such as a decrease in recovery time, increased length of stay in a facility, and the 
increased likelihood of developing chronic pain.  As the nation fights the current opioid 
epidemic, anesthesia providers have an opportunity to decrease the amount of narcotics 
that patients require after surgery by using a multimodal technique.  Spine surgery is 
known for being one of the most painful surgeries for patients, and due to the location of 
incision regional techniques are not beneficial.  Using an intraoperative ketamine infusion 
reduces postoperative pain and is specifically beneficial in the population who receive 
spine surgery.  The majority of spine surgery patients either have chronic back pain 
and/or take opioids to manage their pain preoperatively.  As an N-methyl-D-aspartic acid 
(NMDA) receptor antagonist, by nature ketamine provides a strong neuropathic pain 
relief, but at low doses ketamine also reduces pain sensitivity and opioid tolerance.  An 
intraoperative ketamine infusion reduces acute postoperative pain and decreases the 
amount of opioids required to manage pain after surgery.   
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 In collaboration with a physician anesthesiologist who is currently utilizing 
intraoperative ketamine during spinal surgery cases, I created a policy to facilitate the 
increase in usage of intraoperative ketamine for spine surgery.  The policy includes 
correct dosage, the timing of administration, patient exclusion criteria, and administration 
guidelines.  After the policy was completed, I presented it to a panel of experts that 
included the collaborating physician anesthesiologist, CRNAs, a pharmacist, and a 
hospital administrator.  I provided them with a survey that included questions, such as the 
following: Did this project presentation provide you with information regarding 
intraoperative ketamine administration that reduces postoperative pain for patients 
undergoing spinal surgery? Did the information provided in this presentation encourage 
you to reconsider your current anesthesia practice? And would you consider changing 
your practice based on the information presented if given the option of utilizing ketamine 
as an adjunctive therapy? This doctoral student collected data from their surveys that 
detailed their expert opinion and analyzed the feedback they provided.  I revised my 
policy using information I gathered from their feedback.  Finally, I included the 
recommendations and the finalized policy based on data, literature review, and a panel of 
experts to the physician anesthesiologist at the Orthopedic Institute for his use. 
The survey results revealed that the policy was effective in providing the 
information needed to explain the evidence for the use of intraoperative ketamine to 
reduce postoperative pain in spinal surgery patients.  The participants’ responses revealed 
that they were willing to change their practice to include intraoperative ketamine as an 
adjunctive therapy if the opportunity presents itself.  My recommendation is to 
implement the policy at the facility.  Once the policy is initiated, a retroactive analysis 
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should be performed between the patients who received intraoperative ketamine to those 
in the past who had not received ketamine for their spinal surgery to compare the amount 
of opioids required for pain control and patient satisfaction after the procedure.  By 
comparing the amount of opioids required for pain control postoperatively between 
patients before and after policy implementation, the facility can prove the benefit of 
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